Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Gland Pharma Ltd. ( (IN:GLAND) ) has shared an update.
Gland Pharma Limited has announced a series of scheduled meetings with analysts and institutional investors in November 2025. These meetings, which include group and one-on-one sessions, are part of the company’s ongoing efforts to engage with key stakeholders and provide insights into its operations and future prospects. The meetings are planned with notable financial entities such as HBM Partners, Perpetuity Ventures, ICICI Securities, and JM Financial, reflecting the company’s proactive approach to maintaining transparency and fostering investor relations.
More about Gland Pharma Ltd.
Gland Pharma Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of complex injectables. The company is known for its expertise in producing high-quality generic injectables and has a significant presence in both domestic and international markets.
Average Trading Volume: 7,704
Technical Sentiment Signal: Buy
Current Market Cap: 315.1B INR
Learn more about GLAND stock on TipRanks’ Stock Analysis page.